Related Experiment Video
Updated: May 30, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
M W Heijstek1, L M Ott de Bruin, M Bijl
1Department of Paediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Room KC 03.063.0, PO Box 85090, 3508 AB Utrecht, The Netherlands. m.w.heijstek@umcutrecht.nl
Insights
Vaccination guidelines for children with rheumatic diseases (PaedRD) were established using EULAR procedures. Further research is needed on vaccine safety and effectiveness in this vulnerable pediatric population.
Area of Science:
- Rheumatology
- Immunology
- Vaccinology
- Public Health
Background:
- Paediatric patients with rheumatic diseases (PaedRD) are at increased risk of infections.
- Standardized vaccination protocols are crucial for managing this population.
- Existing guidelines require updates based on current evidence.
Purpose of the Study:
- To develop evidence-based vaccination recommendations for paediatric patients with rheumatic diseases (PaedRD).
- To synthesize current literature on vaccine safety and efficacy in this cohort.
- To identify research gaps in paediatric rheumatology vaccination.
Main Methods:
- Systematic literature review of MEDLINE, EMBASE, and major rheumatology conference abstracts (2008/9).
- EULAR (European Alliance of Associations for Rheumatology) standardised guideline development procedures.
- Delphi voting by a multidisciplinary task force to achieve consensus.
Main Results:
- Fifteen recommendations for vaccination in PaedRD were developed with 91.7% overall agreement.
- Literature primarily focused on seasonal influenza and pneumococcal vaccines.
- Limited studies specifically addressed paediatric populations, with a focus on adult rheumatoid arthritis and systemic lupus erythematosus.
Conclusions:
- Evidence-based vaccination recommendations for PaedRD have been established.
- Significant research gaps exist regarding the safety and immunogenicity of vaccinations, especially live-attenuated vaccines and in patients on biologicals.
- Further investigation is required to understand the impact of vaccination on infection prevention in PaedRD.
Abstract:
Evidence-based recommendations for vaccination of paediatric patients with rheumatic diseases (PaedRD) were developed by following the EULAR standardised procedures for guideline development. The EULAR task force consisted of (paediatric) rheumatologists/immunologists, one expert in vaccine evaluation, one expert in public health and infectious disease control, and one epidemiologist. A systematic literature review was conducted in MEDLINE, EMBASE, and abstracts of the EULAR and American College of Rheumatology meetings of 2008/9. The level of evidence and strength of recommendation were based on customary scoring systems. Delphi voting was applied to assess the level of agreement between task force members. 107 papers and eight abstracts were used. The majority of papers considered seasonal influenza (41) or pneumococcal (23) vaccination. 26 studies were performed specifically in paediatric patients, and the majority in adult rheumatoid arthritis and systemic lupus erythematosus patients. Fifteen recommendations were developed with an overall agreement of 91.7%. More research is needed on the safety and immunogenicity of (live-attenuated) vaccination in PaedRD, particularly in those using biologicals, and the effect of vaccination on prevention of infections.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Respiratory Syncytial Virus Disease
Vaccinations
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction